Jones Robert B

Director at ACURA PHARMACEUTICALS, INC · on record since Dec 19, 2011
President & CEO at ACURA PHARMACEUTICALS, INC · on record since Dec 17, 2018

Insider trading activity of Jones Robert B

Transactions on record: 40; since Apr 7, 2008

Open-market buys: 5; $49.7K

Open-market sells: 0

Companies traded: 1; last filing Nov 20, 2023

Figures computed from official regulatory filings — .

Companies where Jones Robert B has traded

ACURA PHARMACEUTICALS, INC40 tx · $135.8K · Nov 20, 2023

Track record of Jones Robert B

Statistical track record

Free account

Open-market buys: 5

Last buy: Dec 14, 2017

Win rates, median returns and the proven-insider analysis come with a free account.

Create a free account

Transaction history of Jones Robert B

Co-insiders of Jones Robert B

Abuse Deterrent Pharma, LLCACURA PHARMACEUTICALS, INC
Azad DavidACURA PHARMACEUTICALS, INC
Boehm GarthACURA PHARMACEUTICALS, INC
Brzeczko Albert WACURA PHARMACEUTICALS, INC
CARE CAPITAL II LLCACURA PHARMACEUTICALS, INC
CARE CAPITAL INVESTMENTS II LPACURA PHARMACEUTICALS, INC
Care Capital Offshore Investments II LPACURA PHARMACEUTICALS, INC
CLAUDIUS LLCACURA PHARMACEUTICALS, INC
CLEMENS PETER AACURA PHARMACEUTICALS, INC
EMIGH JAMES FACURA PHARMACEUTICALS, INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACURA PHARMACEUTICALS, INCListing on record	Nov 20, 2023	Exercise	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 20, 2023	ExerciseD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 5, 2023	ExerciseD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 5, 2023	Exercise	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	ExerciseD (derivative)	13,666	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	ExerciseD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	Exercise	63,666	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Mar 18, 2022	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Exercise	63,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	13,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	Exercise	13,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	ExerciseD (derivative)	13,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	150,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 15, 2017	Buy	400,000	0.10 USD	$40K	conv 93ClusterUnusual size+1	SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 11, 2017	AwardD (derivative)	41,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 10, 2017	AwardD (derivative)	47,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 12, 2016	AwardD (derivative)	47,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 14, 2015	AwardD (derivative)	70,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 15, 2014	AwardD (derivative)	252,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 3, 2014	Other	-143	1.67 USD	$238.8		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 3, 2014	Other	-11,924	1.67 USD	$19.9K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 13, 2013	AwardD (derivative)	137,500	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 4, 2013	Other	-11,637	2.22 USD	$25.8K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACURA PHARMACEUTICALS, INCListing on record	Nov 20, 2023	Exercise	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 20, 2023	ExerciseD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 5, 2023	ExerciseD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 5, 2023	Exercise	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	ExerciseD (derivative)	13,666	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	ExerciseD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	Exercise	63,666	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Mar 18, 2022	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Exercise	63,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	13,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	Exercise	13,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	ExerciseD (derivative)	13,667	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	150,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 15, 2017	Buy	400,000	0.10 USD	$40K	conv 93ClusterUnusual size+1	SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 11, 2017	AwardD (derivative)	41,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 10, 2017	AwardD (derivative)	47,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 12, 2016	AwardD (derivative)	47,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 14, 2015	AwardD (derivative)	70,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 15, 2014	AwardD (derivative)	252,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 3, 2014	Other	-143	1.67 USD	$238.8		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 3, 2014	Other	-11,924	1.67 USD	$19.9K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 13, 2013	AwardD (derivative)	137,500	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 4, 2013	Other	-11,637	2.22 USD	$25.8K		SEC